|10:00 (5 min.)||Welcome and Introductions||
|10:05 (15 min.)||Corporate Overview||James S. J. Manuso, Ph.D.Chairman and Chief Executive Officer|
|10:20 (15 min.)||Financial Overview||Michael Molkentin, C.P.A.Chief Financial Officer and Corporate Secretary|
|10:35 (15 min.) 10:50 (20 min.)||Clinical UpdateSGI-110 & HMAs||Mohammad Azab, M.D.Chief Medical Officer Jean-Pierre Issa, MDFels Institute of Cancer ResearchTemple University, Philadelphia, PA|
|11:10 (20 min.)||AT 13387 & HSP90 inhibitors||Andrew Wagner, MD, PhDDana Farber Cancer Institute, Boston, MA|
|11:30 (15 min.) 11:45 (15 min.)||Research & DiscoveryPartnering & Corporate Development||Harren Jhoti, Ph.D.President and Director Martin BucklandChief Business Officer|
|12:00 (5 min.)||Closing Remarks||James S. J. Manuso, Ph.D.Chairman and Chief Executive Officer|
Astex Pharmaceuticals Announces March 27th Analyst And Investor Day Agenda
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
Every recommendation goes through 3 layers of intense scrutinyquantitative, fundamental and technical analysisto maximize profit potential and minimize risk.
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.